-
[show abstract]
[hide abstract]
ABSTRACT: The characteristic angle- beta concept in electron arc therapy of non-cylindrical target volumes is applied in determining the required shape of the arced electron field to yield a uniform dose distribution inside the target volume. The empirical relationships derived for this purpose from the angle- beta concept are valid for all field widths and thus offer an improvement over the currently known empirical relationships which were derived as small-field-width approximations. The validity of the determination of field shapes in electron arc therapy with the empirical relationships based on the angle- beta concept is confirmed by measurements of dose distributions in a spherical phantom.
Physics in Medicine and Biology 12/1998; 38(7):999. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The aim of this work was to develop a parameter for use during fractionated stereotactic radiotherapy treatment planning to aid in the determination of the appropriate treatment volume and fractionation regimen that will minimize risk of late damage to normal tissue.
We have used the linear quadratic model to assess the biologically effective dose at the periphery of stereotactic radiotherapy treatment volumes that impinge on the brain stem. This paper reports a retrospective study of 77 patients with malignant and benign intracranial lesions, treated between 1987 and 1995, with the dynamic rotation technique in 6 fractions over a period of 2 weeks, to a total dose of 42 Gy prescribed at the 90% isodose surface. From differential dose-volume histograms, we evaluated biologically effective dose-volume histograms and obtained an integral biologically-effective dose (IBED) in each case.
Of the 77 patients in the study, 36 had target volumes positioned so that the brain stem received more than 1% of the prescribed dose, and 4 of these, all treated for meningioma, developed serious late damage involving the brain stem. Other than type of lesion, the only significant variable was the volume of brain stem exposed. An analysis of the IBEDs received by these 36 patients shows evidence of a threshold value for late damage to the brain stem consistent with similar thresholds that have been determined for external beam radiotherapy.
We have introduced a new parameter, the IBED, that may be used to represent the fractional effective dose to structures such as the brain stem that are partially irradiated with stereotactic dose distributions. The IBED is easily calculated prior to treatment and may be used to determine appropriate treatment volumes and fractionation regimens minimizing possible toxicity to normal tissue.
International Journal of Radiation OncologyBiologyPhysics 02/1998; 40(3):667-75. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The characteristic angle-beta concept provides a simple semiempirical method for determination of dose distributions in electron arc therapy. Initially, the method required a set of measured radial depth dose distributions for each electron beam energy used for arc therapy. In this paper, we report an extension of the angle-beta concept that enables the determination of arc therapy depth doses for an arbitrary electron energy from the known set of depth dose data at a reference energy. Depth dose distributions of stationary and arc electron beams have been studied in the energy range from 9 to 18 MeV. The stationary electron beams used for electron arc therapy were collimated by photon collimators only, no secondary collimation was used in our experiments. For stationary electron beams and for arc electron beams with a given characteristic angle beta, the depths of dose maximum as well as the depths of a given percentage depth dose beyond the depth of dose maximum are linearly proportional to the mean incident electron energy. This simple geometrical and dosimetric relationship increases the potential usefulness of the angle-beta concept in clinical electron arc therapy.
Medical Physics 02/1997; 24(1):127-32. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: This paper reports a dosimetric study of 43 patients treated with a combination of concomitant radiotherapy and chemotherapy (cisplatin) for locally advanced carcinoma of the cervix with the aim of investigating the correlation between the radiation dose to the rectum and the incidence of late rectal complications.
Radiotherapy consisted of 46 Gy external beam irradiation plus three high dose rate intracavitary treatments given weekly, concurrent with the last 3 weeks of external beam therapy, to a total dose of 30 Gy to point A. Cisplatin 30 mg/m2 was given weekly throughout the duration of the external beam irradiation. The brachytherapy irradiated volume was reconstructed from the orthogonal treatment radiographs to accurately locate the reference points defined by the International Commission of Radiation Units and Measurements (ICRU), report 38. The doses calculated at these points were compared to in vivo dose measurements performed immediately prior to treatment.
The group of patients who were calculated to have received a dose to the rectal reference point greater than the prescribed point A dose (9/13) had a significantly greater probability of development of late rectal complications compared to the group of patients who were calculated to have received less than the prescribed point A dose at this rectal point (7/30), p = 0.003. There was no correlation of rate of complication with the in vivo measured dose in the rectum, stage of disease, or age. At 40 months post treatment, the group of patients receiving the higher dose to the rectal reference point had an actuarial rate of serious (Grade 3 and 4) rectal complications of 46% compared to a rate of 14% in the remainder. In terms of survival, the group of patients receiving the higher dose to the rectal reference point have all survived, whereas the group of patients receiving the lower dose to the rectal reference point have a significantly different rate of survival of 72%, p = 0.046.
This investigation has revealed a significant correlation between the dose calculated at the rectal point defined by the ICRU and the incidence of late rectal complications in patients with carcinoma of the cervix undergoing concomitant radiotherapy and chemotherapy. Thus, this rectal reference point appears to be a useful prognostic indicator of late rectal complications in these patients and we recommend that the brachytherapy dose delivered to this rectal point be limited to the dose prescribed to point A for treatment regimens using three fractions of 8-10 Gy each, limiting the total dose to this point, including the external beam component, to 76 Gy. Further study will be required to determine whether this rule should be applied to patients receiving irradiation alone.
International Journal of Radiation OncologyBiologyPhysics 04/1994; 28(5):1243-50. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The excellent treatment results obtained with traditional radiosurgery have stimulated attempts to broaden the range of intracranial disorders treated with radiosurgical techniques. For major users of radiosurgery this resulted in a gradual shift from treating vascular diseases in a single session to treating small, well delineated primary tumors on a fractionated basis. In this paper we present the technique currently used in Montreal for the fractionated stereotactic radiotherapy of selected intracranial lesions.
The regimen of six fractions given every other day has been in use for "fractionated stereotactic radiotherapy" in our center for the past 5 years. Our current irradiation technique, however, evolved from our initial method of using the stereotactic frame for target localization and first treatment, and a "halo-ring" with tattoo skin marks for the subsequent treatments. Recently, we developed a more precise irradiation technique, based on an in-house-built stereotactic frame which is left attached to the patient's skull for the duration of the fractionated regimen. Patients are treated with the stereotactic dynamic rotation technique on a 10 MV linear accelerator (linac).
In preparation for the first treatment, the stereotactic frame is attached to the patient's skull and the coordinates of the target center are determined. The dose distribution is then calculated, the target coordinates are marked onto a Lucite target localization box, and the patient is placed into the treatment position on the linac with the help of laser positioning devices. The Lucite target localization box is then removed, the target information is tattooed on the patient's skin, and the patient is given the first treatment. The tattoo marks in conjunction with the target information on the Lucite target localization box are used for patient set-up on the linac for the subsequent 5 treatments. The location of the target center is marked with radio-opaque markers on the target localization box and verified with a computerized tomography scanner prior to the second treatment. The same verification is done prior to other treatments when the target center indicated by the target localization box disagrees with that indicated by the tattoo marks. The new position of the target center is then determined and used for treatment positioning.
The in-house-built frame is inexpensive and easily left attached to the patient's skull for the 12 day duration of the fractionated regimen. Positioning with the Lucite target localization box verified with tattoo marks ensures a high level of precision for individual fractionated treatments.
International Journal of Radiation OncologyBiologyPhysics 01/1994; 27(5):1225-30. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The combination of external beam irradiation and low-dose-rate brachytherapy is known to be an effective form of treatment in carcinoma of the cervix and any change from this well-established therapeutic combination must be able to equal or improve the treatment results. Since 1984 we have been using high dose rate brachytherapy in conjunction with external beam irradiation for patients with carcinoma of the cervix. This paper reports our long term treatment results in terms of local disease control, survival, and complications.
Between January 1984 and December 1989, 187 previously untreated patients with carcinoma of the cervix underwent combined external beam irradiation and high dose rate brachytherapy. The International Federation of Gynecology and Obstetrics stage distribution of patients was as follows: I B = 15, II A = 35, II B = 68, III A = 9, III B = 54, IV A = 6. External beam irradiation to the whole pelvis was delivered by megavoltage irradiation with once-a-day fractionation, to a median dose of 4600 cGy. High dose rate brachytherapy was delivered by a high-dose-rate remote controlled afterloading unit, containing 20 spherical Cobalt 60 sources with a nominal activity of 19 GBq (0.5 Ci) at the time of installation, giving a typical dose rate to point A of 160 cGy/min, decreasing to about 80 cGy/min at the end of the 5-year study. One to 3 high dose rate brachytherapy treatments delivering 800 to 1000 cGy to point A were given weekly concurrently with the last 2 to 3 weeks of radiation therapy, or following its completion. Maximum rectal and bladder doses were routinely measured for each treatment.
Overall 5-year actuarial survivals were as follows: I B = 72%, II A = 65%, II B = 66%, III A = 66%, III B = 45%. Five-year actuarial pelvic control rates were as follows: I B = 66%, II A = 83%, II B = 78%, III A = 88%, III B = 40%. At a median follow-up time of 54 months for patients at risk, 23 patients developed 25 complications attributable to radiotherapy (13 rectal, 3 bladder, 8 small bowel, 1 fistula) at a median time of 18 months following completion of treatment. Thirteen complications (7.6%) were grades 3 or 4. Patients with Stage II disease had a higher incidence of complications than patients with Stages I and III disease (p < 0.05). Rectal complications were significantly higher in patients who received a total rectal dose > 5400 cGy (p = 0.045).
High-dose-rate brachytherapy treatment results are comparable to those obtained with low dose rate brachytherapy techniques. The use of three high dose rate brachytherapy insertions is a practical, economical, and safe treatment for patients with carcinoma of the cervix.
International Journal of Radiation OncologyBiologyPhysics 12/1993; 27(4):803-9. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Between November 1986 and June 1990, 24 patients were treated with electron pseudoarc therapy at McGill University. There were 21 females and three males aged 27 to 81 years (median 62 years). 17 patients, nine of whom had received previous conventional locoregional irradiation, were treated palliatively for locally extensive breast carcinoma. Eight of these 17 patients achieved a complete, and six a partial, response to treatment; nine subsequently developed evidence of progressive disease within the treatment field after intervals of one to 27 months (median 5 months) following therapy. Eight patients developed moist desquamation of the treated chest wall, which was extensive in four; one of these patients developed chronic ulceration of the skin. The latter and one additional patient developed radiation pneumonitis. Seven patients were treated with radical intent, two following mastectomy for breast carcinoma, and one each for chest wall lymphoma, chest wall sarcoma, scalp angiosarcoma, scalp lymphoma and posterior cervical soft tissue sarcoma. Local control was achieved in six of these seven patients with minimal toxicity. Electron pseudoarc therapy is a treatment option for selected breast carcinoma patients for palliation of extensive chest wall disease, although morbidity may be considerable. The technique may, however, play a more useful role in other situations where the superficial portion of large curved surfaces is to be treated with curative intent.
British Journal of Radiology 04/1993; 66(783):234-40. · 1.31 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Between October 1981 and December 1989, 44 patients with cutaneous T-cell lymphoma (CTCL) were treated with a single field rotational total skin electron irradiation (RTSEI) technique developed in the McGill University, Department of Radiation Oncology. Only 11 (25%) of the 44 patients had received no prior treatment. Three-quarters (33/44) had advanced (T3 or T4) disease. Complete responses were seen in 32/44 (73%) of patients (91% T2, 71% T3 and 58% T4), but only 3/11 (27%) of patients with T2 disease and 3/21 (14%) of patients with T3 disease remain in continuous complete remission in the skin, after median intervals of 58 and 35 months, respectively. Median cause-specific survival for the whole group is 43 months and survival at 5 years is 38%. Survival was significantly better for patients with T2 disease than for patients with T3 disease (relative risk 4.3; 95% CI 1.4-13.2) and patients with T4 disease (relative risk 3.1; 95% CI 0.8-12.1). The RTSEI technique used at McGill has depth-dose characteristics and photon contamination similar to other commonly used TSEI techniques. It is relatively simple and provides a homogenous dose distribution over the entire skin surface in a short treatment time. Results of treatment are similar to those obtained with other techniques. For T2 disease, TSEI is an effective treatment modality with a possibility of long-term tumor control. For more advanced disease, more aggressive treatment, which may include TSEI, is necessary.
Radiotherapy and Oncology 08/1992; 24(3):155-62. · 5.58 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A technique for the determination of treatment parameters that are required to achieve a desired depth dose distribution in electron arc therapy is discussed and a method for calculating isodose distributions is presented. Both the treatment technique and the dose calculation method rely on the angle beta concept, which uniquely describes the dependence of the radial percentage depth doses in electron arc therapy on the nominal field width, isocenter depth, and virtual source-axis distance. The angle beta concept is discussed in detail and the electron pseudo-arc therapy technique used at McGill is described. Also presented is the method used to achieve dose homogeneity in target volumes treated with the pseudo-arc technique.
International Journal of Radiation OncologyBiologyPhysics 07/1991; 20(6):1331-9. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: From January 1984 through December 1986, 87 patients with previously untreated carcinoma of the cervix received external beam pelvic irradiation and high dose rate intracavitary therapy (HDRT). There were 18 Stage IIA patients, 39 Stage IIB, and 30 Stage IIIB. The median age was 60 years and the median follow-up time was 42 months for patients at risk. Radiotherapy consisted of external megavoltage irradiation to the whole pelvis (median dose 4600 cGy) combined with one (6 patients), two (51 patients), or three (30 patients) HDRT insertions. A high dose rate remote afterloading unit with 60Co sources was used to deliver the HDRT. The prescribed dose to point A was between 800 and 1000 cGy per treatment. The dose rate at point A initially was approximately 150 cGy/min and dropped to approximately 100 cGy/min during the duration of the study. Treatments with multiple fractions were given at weekly intervals. The overall actuarial survival at 5 years was 88% for Stage IIA, 64% for Stage IIB and 32% for Stage IIIB patients. Pelvic recurrence remained the major cause of failure. Grade III and IV late complications included proctitis and bowel obstruction in six patients each. We conclude that HDRT results are similar to those obtained with conventional low dose rate intracavitary systems. HDRT is cost effective and minimizes exposure to personnel. Several questions, such as the total number of insertions required, dose per HDRT insertion, and optimal HDRT insertion schedule remain unanswered and further experience is needed to better clarify these issues.
International Journal of Radiation OncologyBiologyPhysics 06/1991; 20(5):921-6. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A personal computer based three-dimensional treatment planning system, which may be used for planning any linear accelerator (Linac) based radiosurgical technique, is presented. The system is used to calculate dose distributions for most of the Linac-based techniques currently in use as well as the theoretically optimum 4 pi geometry. The maximum and minimum dose falloffs are used to compare the various Linac-based radiosurgical techniques. The dynamic rotation technique developed at McGill University is shown to produce distributions with dose falloffs similar to the multiple converging arc techniques used elsewhere and those obtained for the Gamma Unit. Also considered are the effects of beam energy, in the range of 4-25 MV, and beam profiles on the dose distribution.
Stereotactic and Functional Neurosurgery 02/1990; 54-55:519-24. · 1.85 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Measured and calculated dose distributions around selectron applicators, loaded with 60Co high dose rate pellets, are presented. The effect of the stopping screw, spacers, pellets themselves and the applicator wall on the dose distribution is discussed. The measured dose distribution is in almost perfect agreement with the calculated distribution in planes perpendicular to the applicator axis and containing a source. On the applicator axis directly below the applicator the measured dose amounts to about 75% of the calculated value, when only the stopping screw attenuates the beam from a pellet. When the beam is attenuated by spacers in addition to the stopping screw, the discrepancy between the calculated and measured dose may exceed 50%. Clinically relevant source geometries are also discussed. It is shown that for most regions around the applicator the method of a simple addition of dose contributions from individual point sources is an acceptable approximation for the calculation of dose distributions around the selectron applicators.
International Journal of Radiation OncologyBiologyPhysics 12/1987; 13(11):1761-6. · 4.11 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Radiosurgical techniques are becoming increasingly popular for the selective destruction of brain lesions. To ensure precision in the procedure, set-up and treatment of lesions in this manner, we have adopted standard stereotactic methods to allow one to calculate accurately the absorbed dose and also to preserve accuracy in locating the target site in three dimensions. At McGill University, radiosurgery is performed using the dynamic technique, which utilizes the concurrent rotation of both the 10-MV photon beam linear accelerator (from 30 to 330 degrees) and the patient couch (from 75 to -75 degrees) about a common point centered on the target within the lesion. A three-dimensional treatment planning system for the calculation of dose distributions implemented in conjunction with CT, MRI and DSA stereotactic image analysis systems is presented.
Applied neurophysiology 02/1987; 50(1-6):269-73.
-
[show abstract]
[hide abstract]
ABSTRACT: A simple rotational total skin electron irradiation technique utilising a single large field electron beam is presented. Clinical and technical aspects of the technique are discussed and treatment results for the first 10 patients treated for widespread mycosis fungoides reported. The technique is simple and well tolerated by patients, and can easily be implemented in centres utilising electron beam radiotherapy.
British Journal of Radiology 07/1984; 57(678):501-6. · 1.31 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A computerized thermoluminescent (TL) readout technique is presented which considerably improves the precision of dose readout and facilitates the dose information management and storage. The technique is relatively simple and it involves an interface between a commercially available thermoluminescent dosimetry (TLD) analyzer and a minicomputer. Curve fitting, subtraction of unwanted thermogram peaks, background subtraction, studies of TL decay kinetics, and storage of large number of measured TL data are easily performed with the technique.
Medical Physics 10(4):462-6. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A single-field rotational total skin electron irradiation technique has recently been developed at the McGill University for treatment of skin malignancies. The dose received by a given surface point during rotation in a uniform large electron field depends on the radius of rotation of the surface point, on the local radius of curvature of the contour in the vicinity of the point of interest, and on the shadows cast by limbs (arms upon trunk or head and neck, and legs upon each other). A method for calculating the surface dose distribution on a patient is presented accounting for the various parameters affecting the dose. A series of measurements were performed with polystyrene and a humanoid phantom, and an excellent agreement between measured and calculated dose distributions was obtained.
Medical Physics 11(4):539-46. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Measured and calculated dose profiles under partial attenuators which cover only part of the radiation beam are presented. The study was performed for x-ray beams generated with a 4-MV linear accelerator at a source-surface distance of 120 cm in a water phantom for lead attenuators of arbitrary shape but constant thickness. Dose correction factors, which are used to multiply the open beam data to predict doses under partial attenuators, depend strongly on attenuator parameters, such as its thickness, lateral dimensions, and distance from phantom or patient surface, in addition to depending on depths in the phantom. The dose correction factors are calculated with Clarkson sector integration techniques, and the results, in spite of the simplifying assumptions used in the algorithm, generally agree with measured data to within 3%. The calculational method therefore may be applied to general clinical situations in which partial attenuators are used.
Medical Physics 15(4):511-6. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: In radiotherapy, the radiation beam is sometimes shaped so as to deliver different doses to different organs or give a homogeneous dose to structures of different densities. This objective is achieved by the use of attenuating materials introduced into the beam. These attenuators alter the primary as well as the scattered radiation components of the beam. There is at present no accurate method of dose calculation for these situations. Most calculations are performed considering only the effect of the attenuators on the primary radiation beam and can produce large errors in dosimetry. In the present study, the broad beam attenuation is investigated in homogeneous phantoms for various radiation field sizes, photon beam energies, and depths in phantom. A calculational method taking account of primary as well as first scatter radiation is developed. This method predicts reasonably well the transmission through lead attenuators for the various experimental conditions investigated.
Medical Physics 13(6):928-35. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Measured and calculated dose distributions under attenuators, which are of smaller cross-sectional dimensions than the radiation field, are presented. The study was performed on a 4-MV linac at a source-surface distance of 120 cm on the beam central axis in a water phantom for several thickness and cross sections of lead attenuators. Dose correction factors, which are used to multiply the open beam data to get dose distributions under partial attenuators, depend strongly on attenuator parameters and on depths in phantom. A method to calculate dose correction factors for any combination of attenuator parameters and any phantom depth is presented. The calculated dose distributions under partial attenuators agree well with measured data, which indicates that the method can be applied in clinical situations.
Medical Physics 15(2):145-50. · 2.83 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A treatment planning technique for calculation of dose distributions in dynamic stereotactic "radiosurgery" with a 10-MV isocentrically mounted linear accelerator is presented. The treatment planning for dynamic radiosurgery is a three-dimensional problem, since during treatment both the gantry and the couch rotate simultaneously, the gantry from 30 degrees to 330 degrees and the couch from 75 degrees to - 75 degrees. The patient surface and anatomical information is obtained from a family of computed tomography or magnetic resonance scans, and a stereotactic frame is used for target localization, treatment setup, and patient immobilization during the treatment. The dose calculational algorithm follows the gantry and couch rotation in an incremental fashion, and relies on measured stationary beam central axis percentage depth doses and dose profiles to calculate the normalized tissue-maximum-ratio distributions over a matrix of points defined on one of three orthogonal planes (transverse, sagittal, or coronal). The dose calculation algorithm is discussed in detail and calculated dose distributions for single plane and dynamic radiosurgery compared with measured data.
Medical Physics 14(5):780-9. · 2.83 Impact Factor
